Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026)
Ascendis Pharma A (ASND) posted Exchange Rate Effect of $9.5 million for Q1 2026, up 1759.71% sequentially from -$570381.3 in Q4 2025, and up 204.89% YoY from $3.1 million in Q1 2025.
Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Exchange Rate Effect for 13 years, with the latest figure at $9.5 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 204.89% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 168.81% YoY) and the FY2025 annual result came in at -$29.4 million, down 220.75% from the prior year.
- Exchange Rate Effect grew to $9.5 million in Q1 2026 per ASND's latest filing, from -$570381.3 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $9.5 million in Q1 2026 and troughed at -$9.0 million in Q1 2025.
- A 5-year average of -$200866.6 and a median of -$570381.3 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect plunged 9903.63% in 2025, then soared 204.89% in 2026.
- Over 5 years, Exchange Rate Effect stood at $2.3 million in 2022, then tumbled by 171.45% to -$1.6 million in 2023, then surged by 155.03% to $886934.2 in 2024, then tumbled by 164.31% to -$570381.3 in 2025, then soared by 1759.71% to $9.5 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $9.5 million, -$570381.3, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 9.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.47 Mn |
| Mar 31, 2026 | 9.47 Mn |
| Dec 31, 2025 | -570,381.32 |
| Dec 31, 2025 | -570,381.32 |
| Sep 30, 2025 | -1.84 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -9.03 Mn |
| Mar 31, 2025 | -9.03 Mn |
| Dec 31, 2024 | 886,934.18 |
| Dec 31, 2024 | 886,934.18 |
| Sep 30, 2024 | 169,125.80 |
| Sep 30, 2024 | 169,125.80 |
| Jun 30, 2024 | 16,153.31 |
| Jun 30, 2024 | 16,153.31 |
| Mar 31, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Dec 31, 2023 | -1.61 Mn |